LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,780,099
تعداد دریافت فایل اصل مقاله8,803,917
El-Attar, Nahla, Kamel, Lamiaa, Abdelghany, Amany, Haggag, Rasha, Taha, Heba, Mahdy, Entesar, Madkour, Nadia. (1399). Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women. سامانه مدیریت نشریات علمی, 12(1), 28-39. doi: 10.30476/mejc.2020.82770.1100
Nahla I. El-Attar; Lamiaa Mahmoud Kamel; Amany Abdelghany; Rasha Haggag; Heba F. Taha; Entesar R. Mahdy; Nadia M. Madkour. "Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women". سامانه مدیریت نشریات علمی, 12, 1, 1399, 28-39. doi: 10.30476/mejc.2020.82770.1100
El-Attar, Nahla, Kamel, Lamiaa, Abdelghany, Amany, Haggag, Rasha, Taha, Heba, Mahdy, Entesar, Madkour, Nadia. (1399). 'Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women', سامانه مدیریت نشریات علمی, 12(1), pp. 28-39. doi: 10.30476/mejc.2020.82770.1100
El-Attar, Nahla, Kamel, Lamiaa, Abdelghany, Amany, Haggag, Rasha, Taha, Heba, Mahdy, Entesar, Madkour, Nadia. Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women. سامانه مدیریت نشریات علمی, 1399; 12(1): 28-39. doi: 10.30476/mejc.2020.82770.1100

Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women

Middle East Journal of Cancer
مقاله 4، دوره 12، شماره 1 - شماره پیاپی 45، فروردین 2021، صفحه 28-39    اصل مقاله (1.99 M)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/mejc.2020.82770.1100
نویسندگان
Nahla I. El-Attar1؛ Lamiaa Mahmoud Kamel1؛ Amany Abdelghany2؛ Rasha Haggag3؛ Heba F. Taha* 3؛ Entesar R. Mahdy2؛ Nadia M. Madkour2
1Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2Department of Obstetrics and Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
3Department of Medical Oncology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
چکیده
Background: Risk of ovarian malignancy algorithm (ROMA) combining human epididymis secretory protein 4 (HE4) and CA125 is a novel score, specific for epithelial ovarian cancer (EOC).
Method: Our cohort prospective study aimed to evaluate the role of HE4 and ROMA score in the diagnosis of EOC. We determined CA125 and HE4 serum levels in 56 premenopausal women with ovarian mass (38 women with benign ovarian mass and 18 women with malignant ovarian mass), 56 postmenopausal women with ovarian mass (20 women with benign ovarian mass and 36 women with malignant ovarian mass), and 56 healthy women as control.
Results: Serum CA125 and HE4 and ROMA score were significantly higher among postmenopausal group compared with premenopausal and control groups (P< 0.001), and the median serum CA125 and HE4 and ROMA levels were statistically higher among malignant lesions compared with benign lesions and control group (P< 0.001). The sensitivity and specificity of HE4 and ROMA vs. CA125 in discriminating ovarian cancer from benign ovarian tumor was (88% and 98% vs. 90%) and (97% and 99% vs. 80%), respectively. ROMA had better sensitivity and specificity compared to CA125 and HE4 in premenopausal and postmenopausal women (P <0.001) In premenopausal patients, there was a statistically significant difference regarding the area under the curve (AUC) of ROMA vs. CA125 (P=0.004) and ROMA vs. HE4 (P =0.02).
Conclusion: ROMA score showed a better performance in comparison with either CA125 or HE4 alone in premenopausal patients. HE4 and ROMA score significantly differentiated early from late stage ovarian cancer.
کلیدواژه‌ها
Ovarian cancer؛ Prognosis؛ ROMA score؛ CA125؛ HE4
اصل مقاله

How to cite this article:

El-Attar NI, Kamel LM, Abdelghany A, Haggag R, Taha HF, Mahdy ER, Madkour NM. Role of HE4 and ROMA score in diagnosis of ovarian cancer in Egyptian women. Middle East J Cancer. 2021;12(1):28-39. doi: 10.30476/mejc.2020. 82770.1100.

آمار
تعداد مشاهده مقاله: 6,151
تعداد دریافت فایل اصل مقاله: 6,250


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب